Tend Health strikes $270m deal for The Doctors network
Tuesday, 2 June 2026
Tend Health has entered into an agreement to acquire the medical division of Green Cross Health for $270 million.
The technology-enabled healthcare provider will bring 65 medical centres of general practice and urgent care clinics under The Doctors brand into its existing portfolio of 25 GP practices and medical clinics.
Tend has clinics in Auckland, Tauranga, Christchurch and Ashburton.
Green Cross Health says The Doctors served the largest enrolled patient base in New Zealand, delivering primary care to more than 400,000 patients.
The transaction is set to be completed on July 31, conditional on Green Cross Health shareholder approval next month.
The acquisition has the backing of Ngāti Whātua Ōrākei and Ngāi Tahu Holdings, an existing shareholder in Tend.
Read more:
Everlab brings subscription‑based preventative healthcare to NZ
Payments platform Kindo sees surge in parents helping other kids
Tend Health co-founder Cecilia Robinson said the acquisition would position the company well for the future.
“This is about building for the long term. Primary care is one of the most important parts of our health system, with a vital role in prevention, early identification of health concerns and helping our people stay well.
“Within the next 20 years, it is projected that one in three tamariki in Aotearoa me Te Waipounamu will identify as Māori. That is why we believe strong iwi and Māori partnerships matter deeply for the future of health in New Zealand,” Robinson said.
“This is about purpose and people. Tend was founded to help New Zealanders be the healthiest people in the world, and our people remain at the heart of everything we do. We have enormous respect for the legacy of The Doctors, and for the clinical teams who have built trusted relationships with patients and communities over many years.
“Our focus is on supporting that legacy while continuing to invest in the future of primary care in Aotearoa me Te Waipounamu. This is an opportunity to build a 100-year Kiwi-owned healthcare business for future generations.”
In a NZX announcement, Green Cross Health disclosed the proposed sale price, and said the sale would enable the company to “refocus on its core pharmacy business”, its Unichem and Life Pharmacy chains.
“The board will consider options for the most efficient use of the sale proceeds, which may include retaining some proceeds to invest in the growth of the pharmacy division and a distribution or return of capital to shareholders,” the company said.